Michael D Carter
Overview
Explore the profile of Michael D Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Snow S, Brezden-Masley C, Carter M, Dhani N, Macaulay C, Ramjeesingh R, et al.
Curr Oncol
. 2024 Mar;
31(3):1359-1375.
PMID: 38534936
Genomic medicine is a powerful tool to improve diagnosis and outcomes for cancer patients by facilitating the delivery of the right drug at the right dose at the right time...
2.
Loggie J, Barnes P, Carter M, Rayson D, Bethune G
Breast
. 2024 Mar;
75:103715.
PMID: 38520994
Purpose: It remains unclear whether patients with HER2-negative, low-estrogen receptor (ER-low)-positive early breast cancer (BC) benefit from Oncotype DX® (ODX) testing. Methods: We conducted a retrospective review of cases referred...
3.
Levesque M, Wood R, Carter M, Brock J, Kieser K
CMAJ Open
. 2023 Oct;
11(5):E1012-E1019.
PMID: 37907214
Background: Identifying people with Lynch syndrome, a genetic condition predisposing those affected to colorectal, endometrial and other cancers, allows for implementation of risk-reducing strategies for patients and their families. The...
4.
DeCoste R, Carter M, Ly T, Gruchy J, Nicolela A, Pasternak S
Hum Pathol
. 2023 Mar;
140:39-52.
PMID: 36898590
Merkel cell carcinoma (MCC) is an uncommon primary cutaneous neuroendocrine carcinoma associated with an adverse prognosis. In recent years, our understanding of MCC biology has markedly progressed. Since the discovery...
5.
DeCoste R, Walsh N, Gaston D, Ly T, Pasternak S, Cutler S, et al.
Mod Pathol
. 2022 Sep;
35(12):1829-1836.
PMID: 36075957
Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine (NE) carcinoma arising from integration of Merkel cell polyomavirus (MCPyV) DNA into a host cell or from ultraviolet light-induced genetic damage...
6.
Gruchy J, Pasternak S, Ly T, DeCoste R, Fleming K, Moss P, et al.
Hum Pathol
. 2022 Aug;
129:47-55.
PMID: 35944612
Combined Merkel cell carcinomas are hybrid tumors composed of neuroendocrine and other phenotypic (usually squamous) elements. They form a minority of Merkel cell carcinomas (MCCs) as a whole, are usually...
7.
Decoste R, Amemiya Y, Nersesian S, Westhaver L, Lee S, Carter M, et al.
J Clin Med
. 2022 Jul;
11(14).
PMID: 35888003
Genomic profiling of pancreatic cancer using small core biopsies has taken an increasingly prominent role in precision medicine. However, if not appropriately preserved, nucleic acids (NA) from pancreatic tissues are...
8.
Davis O, Cheung K, Brennan A, Lloyd M, Rodrigues M, Pierrat O, et al.
J Med Chem
. 2022 Jun;
65(12):8169-8190.
PMID: 35657291
To identify new chemical series with enhanced binding affinity to the BTB domain of B-cell lymphoma 6 protein, we targeted a subpocket adjacent to Val18. With no opportunities for strong...
9.
Meier-Stephenson F, Meier-Stephenson V, Carter M, Meek A, Wang Y, Pan L, et al.
Alzheimers Dement (N Y)
. 2022 Apr;
8(1):e12283.
PMID: 35415204
Introduction: Alzheimer's disease (AD) is characterized by neurotoxic immuno-inflammation concomitant with cytotoxic oligomerization of amyloid beta (Aβ) and tau, culminating in concurrent, interdependent immunopathic and proteopathic pathogeneses. Methods: We performed...
10.
Park P, Kurek K, DeCoteau J, Howlett C, Hawkins C, Izevbaye I, et al.
Am J Clin Pathol
. 2022 Feb;
158(1):105-111.
PMID: 35195689
Objectives: In precision medicine, where oncologic management is tailored to the individual's clinical and genetic profiles, advanced diagnostic testing provides prognostic information and guides management in a growing number of...